Latest filings (excl ownership)
15-12G
Securities registration termination
15 May 23
EFFECT
Notice of effectiveness
5 May 23
EFFECT
Notice of effectiveness
5 May 23
25-NSE
Exchange delisting
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
POS AM
Prospectus update (post-effective amendment)
4 May 23
POS AM
Prospectus update (post-effective amendment)
4 May 23
8-K
Termination of a Material Definitive Agreement
4 May 23
SC 14D9/A
Tender offer solicitation (amended)
4 May 23
SC TO-T/A
Third party tender offer statement (amended)
4 May 23
UPLOAD
Letter from SEC
2 May 23
UPLOAD
Letter from SEC
1 May 23
SC TO-T/A
Third party tender offer statement (amended)
28 Apr 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
UPLOAD
Letter from SEC
26 Apr 23
SC TO-T/A
Third party tender offer statement (amended)
25 Apr 23
SC 14D9/A
Tender offer solicitation (amended)
24 Apr 23
CORRESP
Correspondence with SEC
24 Apr 23
UPLOAD
Letter from SEC
21 Apr 23
UPLOAD
Letter from SEC
14 Apr 23
UPLOAD
Letter from SEC
14 Apr 23
SC 14D9
Tender offer solicitation
6 Apr 23
SC TO-T
Third party tender offer statement
6 Apr 23
SC14D9C
Written communication relating to third party tender offer
3 Apr 23
8-K
Departure of Directors or Certain Officers
30 Mar 23
UPLOAD
Letter from SEC
30 Mar 23
SC 14D9
Tender offer solicitation
27 Mar 23
8-K
Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
27 Mar 23
DEFA14A
Additional proxy soliciting materials
15 Mar 23
8-K
Other Events
15 Mar 23
8-K
Regulation FD Disclosure
13 Mar 23
S-8
Registration of securities for employees
10 Mar 23
10-K
2022 FY
Annual report
10 Mar 23
DEFA14A
Additional proxy soliciting materials
23 Feb 23
Latest ownership filings
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G
Opaleye Management Inc.
9 Feb 24
SC 13G/A
Cowen Financial Products LLC
2 Feb 24
4
Change in insider ownership
5 May 23
4
KEVIN C TANG
5 May 23
3
Initial statement of insider ownership
5 May 23
SC 13D/A
TANG CAPITAL PARTNERS LP
5 May 23
4
Luisa Salter-Cid
4 May 23
4
Jigar Raythatha
4 May 23
4
RICHARD /CA/ MURRAY
4 May 23
4
PERRY A KARSEN
4 May 23
4
Robert Kamen
4 May 23
4
Robert Iannone
4 May 23
4
Barbara Gayle Duncan
4 May 23
4
Kimberlee C Drapkin
4 May 23
4
Luis Diaz
4 May 23
SC 13G
Opaleye Management Inc.
12 Apr 23
SC 13D/A
TANG CAPITAL PARTNERS LP
7 Apr 23
4
RICHARD /CA/ MURRAY
6 Apr 23
SC 13D/A
TANG CAPITAL PARTNERS LP
28 Mar 23
SC 13D/A
TANG CAPITAL PARTNERS LP
17 Mar 23
4
KEVIN C TANG
14 Mar 23
3
KEVIN C TANG
14 Mar 23
SC 13D
TANG CAPITAL PARTNERS LP
14 Mar 23
SC 13G
TANG CAPITAL PARTNERS LP
6 Mar 23
SC 13G/A
PFM Health Sciences, LP
14 Feb 23
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 23
SC 13G/A
Deep Track Capital, LP
14 Feb 23
SC 13G
BANK OF AMERICA CORP /DE/
14 Feb 23
SC 13G/A
ORBIMED ADVISORS LLC
14 Feb 23
SC 13G/A
Third Rock Ventures II, L.P.
14 Feb 23
SC 13G/A
Cowen Financial Products LLC
23 Jan 23
4
Elizabeth Trehu
11 Jan 23
4
RICHARD /CA/ MURRAY
11 Jan 23
4
Kimberlee C Drapkin
11 Jan 23
4
Hugh M Cole
11 Jan 23
144
Notice of proposed sale of securities
6 Jan 23
144
Notice of proposed sale of securities
6 Jan 23
144
Notice of proposed sale of securities
6 Jan 23
4
Hugh M Cole
3 Aug 22